Life Sciences Outlook 2012 Dutch biotech companies ... - NautaDutilh
Life Sciences Outlook 2012 Dutch biotech companies ... - NautaDutilh
Life Sciences Outlook 2012 Dutch biotech companies ... - NautaDutilh
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
The Netherlands<br />
Belgium<br />
Bart van Kempen<br />
Florence Verhoestraete<br />
Amsterdam<br />
T: +31 20 71 71 868<br />
M: +31 32 21 40 218<br />
E: bart.vankempen@nautadutilh.com<br />
Bart van Kempen specializes in corporate law<br />
and advises clients in a variety of transactions,<br />
in particular in mergers and acquisitions (both<br />
national and cross-border), controlled auctions and<br />
private equity. He is regularly involved in investment<br />
transactions in the <strong>biotech</strong> industry and has advised<br />
several <strong>biotech</strong> start-ups on various corporate<br />
aspects. Before specializing in mergers and<br />
acquisitions, Bart was a member of the commercial<br />
litigation team.<br />
Partner<br />
Brussels<br />
T: +32 25 66 84 52<br />
M: +32 479 52 01 30<br />
E: florence.verhoestraete@nautadutilh.com<br />
Florence Verhoestraete specializes in intellectual<br />
property law with a particular focus on patents,<br />
trademarks and unfair competition. Her clients work<br />
mainly in the food, consumer goods and life-sciences<br />
sectors. She advises on and litigates in relation to<br />
intellectual property, contractual and regulatory<br />
issues.<br />
<strong>Life</strong> <strong>Sciences</strong> <strong>Outlook</strong> <strong>2012</strong> <strong>Dutch</strong> <strong>biotech</strong> <strong>companies</strong>: from start-up to exit<br />
49
Change language